Amiodarone can still be a drug of choice at emergency departments for pre-excited atrial fibrillation even in the face of guidelines prohibition

Abstract

Electrical cardioversion or intravenous ibutilide are currently recommended as the acute treatment for pre-excited atrial fibrillation. Recent guidelines for this circumstance forbid intravenous amiodarone despite its effectiveness in blocking the accessory pathway and atrioventricular node due to the possibility of ventricular fibrillation. But as our presented case, some physicians continued to favor intravenous amiodarone successfully in a suitable setting.

Keywords

• Atrial Fibrillation
• Wolf-Parkinson-White Syndrome
• Pre-excitation
• Amiodarone